Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1833 AT-130Summary: AT-130, a phenylacrylamide derivative, is a potent non-nucleoside inhibitor of hepatitis B virus replication. -
BA1834 ElebsiranSummary: An siRNA against hepatitis B virus and hepatitis D virus (HDV) infection. -
BA1835 AB-836Summary: AB-836 is an orally active coat inhibitor. -
BA1836 AB-423Summary: AB-423 is a coat assembly inhibitor. -
BA1837 HBV-IN-4Summary: HBV-IN-4, a phthalazinone derivative, is a potent replication inhibitor with oral activity. -
BA1838 TorcitabineSummary: Torcitabine (2'-Deoxy-L-cytidine) is an antivirally active molecule. -
BA1839 FNC-TPSummary: FNC-TP is the intracellular active form of FNC. -
BA1840 InarigivirSummary: Inarigivir (ORI-9020; SB-9000) is a dinucleotide antiviral compound that significantly reduces DNA in transgenic mice expressing hepatitis B virus. -
BA1841 BA-53038BSummary: BA-53038B is a core protein alteration modulator (CpAM) that binds to the HAP pocket and regulates coat assembly. -
BA1842 AlamifovirSummary: Alamifovir (LY582563; MCC-478) is a purine nucleotide analog precursor that shows potent activity against wild-type and lamivudine-resistant hepatitis B virus.

